Charlton Pharmacy Residents
Current Residents
Faith Collum, PharmD
- Major research project: Welcome to the Block Party: Comparing Local Anesthetics Used in Total Hip and Knee Arthroplasties
Past Residents

Jessica Doan, PharmD
2024-2025 PGY1 Resident
- Major research project: Evaluating the impact of a pharmacy auto-discontinuation protocol on vancomycin duration and adverse events
- CE Seminar: Review and aDAPT the Management of Percutaneous Coronary Intervention (PCI)
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- Extravasation protocol
- Updated the stability of anti-neoplastic compounded agents chart
- First position after finishing PGY1: Oncology ambulatory care pharmacist at University of Texas Southwestern Medical Center

Delilah Knapp, PharmD
2024-2025 PGY1 Pharmacy Resident
- Major research project: Assessing Variations in DKA Protocol Compliance and Safety Outcomes between emergency medicine and inpatient units
- CE Seminar: Hemophilia A/B and Von Willebrand Disease
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- Updated pharmacy autosubstitution protocol with ten new drugs
- Created autosubstitution protocol for phosphate binders based on lab values
- Urine and blood culture pharmacist decision-making guideline
- First position after finishing PGY1: PGY2 Emergency Medicine Residency at Riverside University Health System

Hannah Noxon, PharmD
2023-2024 PGY1 Pharmacy Resident
- Major research project: Treatment of mild to moderate diabetic ketoacidosis on an intermediate care unit utilizing a nursing-driven intravenous protocol
- CE Seminar: Evaluation of DOAC use in patients with altered gastrointestinal systems
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- Updated pharmacy anticoagulation protocol
- Dornase alfa drug class review and MUE
- First position after finishing PGY1: PGY2 Critical Care Residency at University Health System
- Current position: Emergency medicine pharmacist specialist at Methodist Charlton Medical Center

Rachel Chock, PharmD
2022-2023 PGY1 Pharmacy Resident
- Major research project: Clinical impact of a pharmacist-driven diabetes clinic on a suburban Dallas population in a “COVID-19 experienced” healthcare setting
- CE Seminar: ADA guideline update and pipeline drugs for diabetes
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- Chemotherapy reference chart
- Stability of reconstituted compounded items
- Palonosetron autosubstitution
- Retacrit auto-discontinuation policy MUE and formulary restriction update
- First position after finishing PGY1: Transitions of Care Pharmacist at University of Texas Southwestern Medical Center
- Current position: Transplant pharmacist specialist at University of Texas Southwestern Medical Center

Leandra Garcia, PharmD
2022-2023 PGY1 Pharmacy Resident
- Major research project: Evaluation of the use of tranexamic acid (TXA) for ACE inhibitor-induced angioedema in the emergency department
- CE Seminar: ACE inhibitor-induced angioedema treatment
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- RSI Order set
- Hypertonic saline IV administration guidelines update
- Sugammadex formulary addition
- First position after finishing PGY1: PGY2 emergency medicine at UW Health Swedish-American Hospital
- Current position: Emergency medicine specialist at Methodist Charlton Medical Center

Kevin Burnham
2021-2022 PGY1 Pharmacy Resident
- Major research project: Utility assessment of a pharmacy to dose Daptomycin protocol: a retrospective cohort study
- CE Seminar: Review of antimicrobial-resistant gram negative infection (AMR 2.0) treatment guidelines
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- Peripheral administration of hypertonic saline and mannitol
- Humate-P dosing and preparation review for pharmacists
- Kcentra formulary restriction updates and MUE
- Creation of hypertriglyceridemia-induced pancreatitis order set
- Creation of peritoneal dialysis order set, including antimicrobials
- First position after finishing PGY1: Emergency medicine specialist at Methodist Charlton Medical Center
- Current position: Entered medical school in 2025

Rubya Khalid, PharmD
2020-2021 PGY1 Pharmacy Resident
- Major research project: Comparison of vancomycin AUC outcomes – beyond the guidelines for serious MRSA infections
- CE Seminar: Anticoagulation use in COVID-19
- Changes to hospital or pharmacy practice made during PGY1 residency year:
- Creation of an argatroban-warfarin bridging treatment guideline
- First position after finishing PGY1: PRN Clinical pharmacist at Methodist Charlton Medical Center
- Current position: PRN Clinical pharmacist at Methodist Charlton Medical Center
